When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...
“[...] these inexpensive, widely available tests with rapid turnaround times and relatively short half-lives (CEA, CA-125, and CA19-9) are perfectly situated to ...
A new research paper was published in Oncotarget's Volume 15 on June 13, 2024, entitled, "Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management ...
Changing the standard sequence of treatment for operable pancreatic cancer could improve survival for some patients, say researchers. Some patients with operable disease and elevated levels of the CA ...
Tumor marker blood tests may help inform various aspects of cancer care, including diagnosis, staging, treatment planning, and outlook. However, they’re often not the only diagnostic tests used. If ...
However, tumor marker tests aren’t the only tools they’ll use in cancer care. Other testing techniques will help provide a more comprehensive look at your type of cancer. Regular cells may produce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results